Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Randomized Controlled Trial of ProstAtak® Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02768363
Recruitment Status : Recruiting
First Posted : May 11, 2016
Last Update Posted : April 3, 2019
Sponsor:
Information provided by (Responsible Party):
Advantagene, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2019
  Study Completion Date : No date given